Clinical Trials Logo

Clinical Trial Summary

The researchers are doing this study to find out whether the combination of pembrolizumab and cryoablation is a safe treatment that causes few or mild side effects in people with mesothelioma. They will also look at whether the combination of pembrolizumab and cryoablation is effective against participants' cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05071014
Study type Interventional
Source Memorial Sloan Kettering Cancer Center
Contact Michael Offin, MD
Phone 646-608-3763
Email [email protected]
Status Recruiting
Phase Phase 1
Start date September 24, 2021
Completion date September 2023